Discover

News & Info

Trade

LongbridgeAI

Quote List Quote List

Compass Pathways(CMPS.US)

Event Tracking

Mar28

LifeSci Capital Maintains Buy Rating on COMPASS Pathways

15:11

Mar25

Oppenheimer and Morgan Stanley Maintain Buy Rating on COMPASS Pathways

16:36

H.C. Wainwright Analyst Reiterates Buy Rating on COMPASS Pathways

14:37

Compass Pathways released FY2025 Q4 earnings on March 24 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.004 (forecast USD -0.405)

03:00

Compass Pathways released FY2025 Annual Earnings on March 24 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -3.0785 (forecast USD -2.2618)

03:00

Mar24

Compass Pathways Plans to Submit NDA by End of 2026 and Extend Cash Runway to 2028

11:40

Schedules & Filings

Schedules

Filings

Mar24

Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income -93.88 M, EPS -1.0025

Nov4

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -137.72 M, EPS -1.4445

Jul31

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -38.4 M, EPS -0.4114

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

Compass Pathways(CMPS.US)

Compass Pathways Stock Performance Chart